Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Eriodictyol 7-o-beta-rutinoside
1. Eriodictioside
2. 13463-28-0
3. Eriodictyol-7-o-rutinoside
4. Eriodictyol 7-o-rutinoside
5. Chebi:28709
6. Eriodictyol 7-rutinoside
7. As293hr5xq
8. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
9. Unii-as293hr5xq
10. Eriodictyol 7-o-beta-rutinoside
11. Einecs 236-668-7
12. Eriodictyol Glycoside
13. Eriocitrin [who-dd]
14. Schembl750974
15. Eriocitrin, Analytical Standard
16. Chembl2165586
17. Dtxsid60864408
18. Eriocitrin, >=98.0% (hplc)
19. Ex-a6774
20. Hy-n0636
21. Zinc8234294
22. Bdbm50462417
23. Mfcd28016053
24. S9211
25. Akos030573687
26. Ccg-208387
27. Ncgc00163549-01
28. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
29. (s)-7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4h-benzopyran-4-one
30. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (s)-
31. As-75208
32. Cs-0009665
33. C09732
34. A910366
35. Sr-05000002278
36. Eriocitrin, Primary Pharmaceutical Reference Standard
37. Sr-05000002278-2
38. Q13567664
39. Glucopyranoside, Eriodictyol-7 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
40. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one
41. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-4-one
42. (s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)chroman-4-one
43. (s)-3',4',5,7-tetrahydroxyflavanone-7-[6-o-(alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside]
44. 4h-1-benzopyran-4-one, 7-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2s)-
45. 4h-1-benzopyran-4-one,7-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2s)-
46. Flavanone, 3',4',5,7-tetrahydroxy-, 7-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
| Molecular Weight | 596.5 g/mol |
|---|---|
| Molecular Formula | C27H32O15 |
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 6 |
| Exact Mass | 596.17412031 g/mol |
| Monoisotopic Mass | 596.17412031 g/mol |
| Topological Polar Surface Area | 245 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 924 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Eriocitrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eriocitrin, including repackagers and relabelers. The FDA regulates Eriocitrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eriocitrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eriocitrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eriocitrin supplier is an individual or a company that provides Eriocitrin active pharmaceutical ingredient (API) or Eriocitrin finished formulations upon request. The Eriocitrin suppliers may include Eriocitrin API manufacturers, exporters, distributors and traders.
click here to find a list of Eriocitrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Eriocitrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eriocitrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eriocitrin GMP manufacturer or Eriocitrin GMP API supplier for your needs.
A Eriocitrin CoA (Certificate of Analysis) is a formal document that attests to Eriocitrin's compliance with Eriocitrin specifications and serves as a tool for batch-level quality control.
Eriocitrin CoA mostly includes findings from lab analyses of a specific batch. For each Eriocitrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eriocitrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Eriocitrin EP), Eriocitrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eriocitrin USP).
LOOKING FOR A SUPPLIER?
